The British Society for Rheumatology has moved toward a life course approach when updating guidelines for several rheumatic ...

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices ...

Novel oral agent nerandomilast slowed lung capacity decline in patients with non-idiopathic pulmonary fibrosis (IPF) ...

Depemokimab reduces exacerbations regardless of baseline asthma control, suggesting uncontrolled symptoms are not necessary ...

Endurance Techn, Solar Ind, GlaxoSmithKline, Gland, and Motilal Oswal marked their presence among the top gainers in the ...

Nifty Pharma stocks, including GSK, Jubilant Pharmova, Eris Life, Gland Pharma and Torrent Pharma, saw gains up to 8% as ...

The NIFTY MIDCAP 150's movements reflect ongoing market dynamics, with Global Health, JSW Infra, and GlaxoSmithKline ...

Current treatment paradigms for lupus nephritis offer significant room for improvement, according to a presenter at the ...

Tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin approved for add-on severe asthma treatment in 2021 ...

The company is working closely with the contract manufacturing facility for resumption of operations. Shares of ...

Peter Humphrey, a former journalist and private investigator, believes a Chinese surveillance team were monitoring his group ...